维生素D和甲胺的联合治疗:一种潜在的方法来缓解2型糖尿病患者的丸功能障碍
Adeyemi Fatai Odetayo1, Halimat Amin Abdulrahim2, Adedotun Muiz Yusuf3
1Physiology Department, Faculty of Basic Medical Sciences, Federal University of Health Sciences, Ila-Orangun, Nigeria. adeyemiodetayo@gmail.com.
Reproductive sciences (Thousand Oaks, Calif.)
|September 24, 2024
概括
维生素D可以增强甲福林的功效.
科学领域:
- 内分泌学和新陈代谢学
- 生殖生物学 生殖生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 2型糖尿病 (T2DM) 呈现异质性,通常用甲胺 (MET) 治疗.
- 长期使用甲福明可能会导致胰腺氧化β细胞损伤.
- 对于出现并发症的T2DM患者,需要使用替代疗法.
研究的目的:
- 研究维生素D和甲胺对T2DM诱导的丸功能障碍的协同作用.
- 评估联合维生素D和甲福林治疗对糖尿病大鼠代谢和激素参数的影响.
主要方法:
- 三十只雄性Wistar大鼠被分为五组:对照组,未经治疗的糖尿病组,糖尿病+维生素D组,糖尿病+甲福林组和糖尿病+维生素D组.
- 治疗时间为28天.
- 血液和丸组织分析了各种生化和荷尔蒙标志物.
主要成果:
- 维生素D提高了甲福明在治疗高血糖和脂质代谢障碍方面的疗效.
- 组合疗法显著增加了白质化激素,卵泡刺激激素,丸激素和5α减少酶活性.
- 维生素D增强了甲福明的抗氧化和抗炎作用,减少丸组织中的氧化应激标志物.
结论:
- 维生素D增强了甲胺在治疗T2DM诱导的丸功能障碍方面的治疗益处.
- 组合维生素D和甲福林治疗提供了一种有希望的方法来缓解与T2DM相关的代谢和生殖并发症.
相关概念视频
Oral Hypoglycemic Agents: Biguanides and Glitazones
182
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
182
Diabetes Mellitus: Type 2 and Gestational
2.2K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.2K
Diabetes: Management and Pharmacotherapy
244
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
244
Diabetes Mellitus: Overview and Type I Subtype
2.5K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.5K
Carbohydrate Metabolism
10.9K
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
10.9K
Insulin: Dosing Regimen and Adverse Effects
156
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
156


